Cryoport Inc (OTCBB: CYRX) has been chosen by Immudex to support its global distribution of biological materials and samples for proficiency panels to and from Immudex’s production and research facilities and customers.
Immudex, based in Denmark and with North American operations in Virginia, provides a portfolio of products and services for the immunotherapy and vaccine development community, including MHC Dextramer reagents for the monitoring of antigen-specific T cells and conduction of the annual MHC Multimer and Elispot Proficiency Panels worldwide. Immudex’s goal is to enable simple, accurate, and reproducible monitoring of antigen-specific T cells in scientific and clinical research, patient care, and to promote routine use of these technologies in diagnostics, research, as well as vaccine and immunotherapy development. More about Immudex can be found at www.immudex.com.
Liselotte Brix, chief operating officer at Immudex, said, “In our research and development we use patient blood samples, available in limited quantity. Cryoport’s solution allows transportation of these precious samples between us and collaborators without degradation of sample material. This ensures optimal sample usage and supports high-quality research.”
Charlotte Halgreen, proficiency panel coordinator at Immudex, said, “We distribute cell samples for proficiency panel participants all over the world. Cryoport provides a complete solution, which includes logistics handling and shipment in temperature-controlled dry vapor shippers, which allow consistent shipment conditions. This collaboration ensures a smooth and on-time delivery of uniform samples.”
“We are pleased to be working with Immudex,” said Jerrell Shelton, chief executive officer of Cryoport. “Using our unique Cryoport Express liquid nitrogen dry vapor shippers, Cryoportal logistics management technology, and unparalleled logistics expertise providing monitoring and intervention capability, we believe Immudex will benefit significantly from Cryoport’s solutions.”
Cryoport provides cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. Its competencies range from skilled, total turnkey management of the entire cold chain logistics process to complex total management services for outsourced cold chain logistics.
For more information, access www.cryoport.com.